Novartis CEO on development of AI tech in health care

CNBC Television published this video item, entitled “Novartis CEO on development of AI tech in health care” – below is their description. CNBC’s Evolve Global Summit is a virtual conference of top business leaders with content from around the world. CNBC’s Julianna Tatelbaum joined “Squawk Box” on Wednesday with some of the highlights from the … Read more Novartis CEO on development of AI tech in health care

Novartis CEO on new cancer therapy programs

CNBC Television published this video item, entitled “Novartis CEO on new cancer therapy programs” – below is their description. CNBC’s Meg Tirrell talks to Dr. Vasant Narasimhan, CEO of Novartis, about his company’s new cancer therapy, which uses targeted microdoses of radiation to combat cancer. For access to live and exclusive video from CNBC subscribe … Read more Novartis CEO on new cancer therapy programs

$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News

BBC News published this video item, entitled “$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News” – below is their description. A baby boy has become one of the first patients to be treated on the UK’s NHS with Zolgensma, the world’s most expensive medicine. Little Arthur is one of around 40 … Read more $2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News

Baby Arthur to get world’s most costly medicine @BBC News live 🔴 BBC

BBC published this video item, entitled “Baby Arthur to get world’s most costly medicine @BBC News live 🔴 BBC” – below is their description. Subscribe and 🔔 to OFFICIAL BBC YouTube 👉 https://bit.ly/2IXqEIn Stream original BBC programmes FIRST on BBC iPlayer 👉 https://bbc.in/2J18jYJ 🔘 Subscribe and 🔔 @BBC News 👉 https://bit.ly/3a1zyip 🔘 Stream BBC News … Read more Baby Arthur to get world’s most costly medicine @BBC News live 🔴 BBC

Novartis Can Help Other Companies Make Covid Vaccines

Bloomberg Markets and Finance published this video item, entitled “Novartis Can Help Other Companies Make Covid Vaccines” – below is their description. Jan.28 — Novartis AG CEO Vas Narasimhan tells Bloomberg Television that the drugmaker is in talks with “a range of different players” to help produce other companies’ Covid-19 vaccines or treatments, potentially adding another pharma giant’s … Read more Novartis Can Help Other Companies Make Covid Vaccines

Novartis CEO discusses developing a new Covid-19 treatment

CNBC Television published this video item, entitled “Novartis CEO discusses developing a new Covid-19 treatment” – below is their description. Vas Narasimhan, Novartis CEO, joins ‘Closing Bell’ to talk about developing a new Covid-19 treatment that uses something called DARPin (Designed Ankyrin Repeat Proteins) “We hope by the summer to get additional data,” Narasimhan said. … Read more Novartis CEO discusses developing a new Covid-19 treatment

Novartis CEO: Hopeful to Accelerate Growth in Second Half

Bloomberg Markets and Finance published this video item, entitled “Novartis CEO: Hopeful to Accelerate Growth in Second Half” – below is their description. Jan.26 — Vas Narasimhan, chief executive officer at Novartis AG, discusses his outlook for the second half of the year, the vaccine rollout and the long-term impact of Covid-19. He speaks on … Read more Novartis CEO: Hopeful to Accelerate Growth in Second Half

Novartis CEO ‘Cautiously Optimistic’ on Covid Impact in Fourth Quarter

Bloomberg Markets and Finance published this video item, entitled “Novartis CEO ‘Cautiously Optimistic’ on Covid Impact in Fourth Quarter” – below is their description. Oct.27 — Novartis Chief Executive Officer Vas Narasimhan discusses the business impact of Covid-19, the race for a vaccine, and the company’s development of a coronavirus antibody treatment. He speaks on … Read more Novartis CEO ‘Cautiously Optimistic’ on Covid Impact in Fourth Quarter

Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

Bloomberg Markets and Finance published this video item, entitled “Leaders with Lacqua: Vasant Narasimhan, Novartis CEO” – below is their description. Sep.04 — Francine Lacqua speaks with Vas Narasimhan, the CEO of Novartis about the race for a coronavirus vaccine, trust in pharmaceutical companies, advances in gene and cell therapies and leadership in a crucial … Read more Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption

Jul.21 — Novartis AG Chief Executive Officer Vasant Narasimhan discusses second-quarter earnings, efforts to find a Covid-19 vaccine, and growth prospects. He speaks on “Bloomberg Markets: European Open” after the Swiss drugmaker trimmed its sales forecast for the year as the coronavirus pandemic hit demand for the eye drug Lucentis and other medicines.

What Are `GRANOLAS’ and Why Does Goldman Sachs Like Them?

GRANOLAS according to Goldman Sachs, are the top companies to invest in right now. This Bloomberg video introduces the concept. May.01 — In Europe, top companies for the next market cycle are firms with strong balance sheets, low volatility growth and good dividend yields, according to strategists at Goldman Sachs Group Inc. Dubbed GRANOLAS, these … Read more What Are `GRANOLAS’ and Why Does Goldman Sachs Like Them?

Trump Repeats False Claim That FDA Approved Malaria Drug Chloroquine for Covid-19

While speaking to U.S. state governors at FEMA headquarters in Washington, D.C. on Thursday, President Trump, again, said the FDA had approved malaria drug chloroquine for treatment of Covid-19, a claim the FDA has denied. #Coronavirus #Covid19 #Chloroquine Earlier Thursday during an at-times-confusing White House press conference, Trump said that chloroquine was approved for use … Read more Trump Repeats False Claim That FDA Approved Malaria Drug Chloroquine for Covid-19

Finding Coronavirus Vaccine Could Take More Than a Year: Novartis CEO

Jan.29 — Novartis AG Chief Executive Officer Vas Narasimhan discusses sales growth, efforts to find a vaccine for the deadly coronavirus spreading from China to countries around the world, and cost savings. Narasimhan talks with Bloomberg’s Annmarie Hordern in Basel, Switzerland on “Bloomberg Markets: European Open.”

Novartis Can Meet Growing Demand for Gene Therapy: CEO

Jan.23 — Vas Narasimhan, chief executive officer at Novartis, discusses demand for gene therapy, the company’s new medicine portfolio and generic drug unit, and commitment to sustainability. He speaks with Bloomberg’s Francine Lacqua at the World Economic Forum’s annual meeting in Davos, Switzerland on “Bloomberg Surveillance.”